Literature DB >> 8443238

Structural and functional properties of natural and chemical variants of apolipoprotein A-I.

A Jonas1, A von Eckardstein, L Churgay, W W Mantulin, G Assmann.   

Abstract

Four isoforms of human apolipoprotein A-I (apo A-I): the normal allele product and the corresponding Lys-107 deletion mutant, and apo A-I with sulfoxidized Met-112 and Met-148 residues and the corresponding reduced form, were investigated in their lipid binding properties, structures, and abilities to activate lecithin-cholesterol acyltransferase. All apo A-I isoforms reacted completely with palmitoyloleoylphosphatidylcholine to give reconstituted high density lipoprotein (rHDL) particles with diameters of 96 A. These particles reacted with low density lipoprotein (LDL) and lecithin-cholesterol acyltransferase (LCAT) equally well, except that the Lys-107 deletion mutant was resistant to structural rearrangements in the presence of LDL. The spectral measurements revealed only minor structural differences among the free apo A-I forms or among their rHDL products, but showed a decreased stability of the Lys-107 deletion mutant and the isoform with reduced Met towards denaturation by guanidine hydrochloride. The results demonstrate that these specific alterations of the apo A-I sequence, which change the helix orientation and hydrophobic moment in one or two putative lipid binding regions, are not sufficient to disrupt the overall properties of the apo A-I complexes with lipid nor to impair significantly their ability to activate LCAT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443238     DOI: 10.1016/0005-2760(93)90098-t

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.

Authors:  Olga Gursky; Xiaohu Mei; David Atkinson
Journal:  Biochemistry       Date:  2011-12-29       Impact factor: 3.162

2.  Apolipoprotein A-I Helsinki promotes intracellular acyl-CoA cholesterol acyltransferase (ACAT) protein accumulation.

Authors:  Juan D Toledo; Horacio A Garda; Laura V Cabaleiro; Angela Cuellar; Magali Pellon-Maison; Maria R Gonzalez-Baro; Marina C Gonzalez
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

3.  Binding of human apoA-I[K107del] variant to TG-rich particles: implications for mechanisms underlying hypertriglyceridemia.

Authors:  Irina N Gorshkova; Xiaohu Mei; David Atkinson
Journal:  J Lipid Res       Date:  2014-06-11       Impact factor: 5.922

4.  Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in women.

Authors:  J R Nofer; A von Eckardstein; H Wiebusch; W Weng; H Funke; H Schulte; E Köhler; G Assmann
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.